Skip to main content
Journal cover image

Long-term predictors of morbidity and mortality in patients following LVAD replacement.

Publication ,  Journal Article
Jimenez Contreras, F; Rames, JD; Schroder, J; Russell, SD; Katz, J; Omer, T; Barac, YD; Milano, C
Published in: Artif Organs
February 2024

BACKGROUND: As heart transplant guidelines evolve, the clinical indication for 73% of durable left ventricular assist device (LVAD) implants is now destination therapy. Although completely magnetically levitated LVAD devices have demonstrated improved durability relative to previous models, LVAD replacement procedures are still required for a variety of indications. Thus, the population of patients with a replaced LVAD is growing. There is a paucity of data regarding the outcomes and risk factors for those patients receiving first-time LVAD replacements. METHODS: The study cohort consisted of all consecutive patients between 2006 and 2020 that received a first-time LVAD replacement at a single institution. Preoperative clinical and laboratory variables were collected retrospectively. The primary endpoint was death or need for an additional LVAD replacement. Data were subjected to Kaplan-Meier, univariate, and multivariate Cox hazard ratio analyses. RESULTS: In total, 152 patients were included in the study, of which 101 experienced the primary endpoint. On multivariate analysis, patients receiving HeartMate 3 (HM3) LVADs as the replacement device showed superior outcomes (HR 0.15, 95% CI 0.065-0.35, p < 0.0001). Independent risk factors for death or need for additional replacement included preoperative extracorporeal membrane oxygenation (ECMO) (HR 4.44, 95% CI 1.87-14.45, and p = 0.00042), increased number of sternotomies (HR 5.20, 95% CI 1.87-14.45, and p = 0.0016), and preoperative mechanical ventilation (HR 1.98, 95% CI 1.01-3.86, and p = 0.045). CONCLUSIONS: Replacement with HM3 showed superior outcomes compared to all other pump types when controlling for both initial pump type and other independent predictors of death or LVAD replacement. Preoperative ECMO, mechanical ventilation, and multiple sternotomies also increased the odds for death or the need for subsequent replacement.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Artif Organs

DOI

EISSN

1525-1594

Publication Date

February 2024

Volume

48

Issue

2

Start / End Page

157 / 165

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Morbidity
  • Humans
  • Heart-Assist Devices
  • Heart Transplantation
  • Heart Failure
  • Biomedical Engineering
  • 4003 Biomedical engineering
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jimenez Contreras, F., Rames, J. D., Schroder, J., Russell, S. D., Katz, J., Omer, T., … Milano, C. (2024). Long-term predictors of morbidity and mortality in patients following LVAD replacement. Artif Organs, 48(2), 157–165. https://doi.org/10.1111/aor.14651
Jimenez Contreras, Fabian, Jess David Rames, Jacob Schroder, Stuart D. Russell, Jason Katz, Tariq Omer, Yaron D. Barac, and Carmelo Milano. “Long-term predictors of morbidity and mortality in patients following LVAD replacement.Artif Organs 48, no. 2 (February 2024): 157–65. https://doi.org/10.1111/aor.14651.
Jimenez Contreras F, Rames JD, Schroder J, Russell SD, Katz J, Omer T, et al. Long-term predictors of morbidity and mortality in patients following LVAD replacement. Artif Organs. 2024 Feb;48(2):157–65.
Jimenez Contreras, Fabian, et al. “Long-term predictors of morbidity and mortality in patients following LVAD replacement.Artif Organs, vol. 48, no. 2, Feb. 2024, pp. 157–65. Pubmed, doi:10.1111/aor.14651.
Jimenez Contreras F, Rames JD, Schroder J, Russell SD, Katz J, Omer T, Barac YD, Milano C. Long-term predictors of morbidity and mortality in patients following LVAD replacement. Artif Organs. 2024 Feb;48(2):157–165.
Journal cover image

Published In

Artif Organs

DOI

EISSN

1525-1594

Publication Date

February 2024

Volume

48

Issue

2

Start / End Page

157 / 165

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Morbidity
  • Humans
  • Heart-Assist Devices
  • Heart Transplantation
  • Heart Failure
  • Biomedical Engineering
  • 4003 Biomedical engineering
  • 1103 Clinical Sciences